Improved Surgical Outcomes for Breast Cancer Patients Receiving Neoadjuvant Aromatase Inhibitor Therapy: Results from a Multicenter Phase II Trial

Multicenter Phase

Neuropsychological Functioning in Breast Cancer Patients Receiving Adjuvant Aromatase Inhibitor Therapy

PsycEXTRA Dataset ◽

10.1037/e684272011-001 ◽

2011 ◽

Author(s):

Jacqueline R. Weaver ◽

Shauna M. Stark ◽

Karineh T. Shaverdi ◽

Stacie Jeter ◽

Jane Zorzi ◽

...

Keyword(s):

Breast Cancer ◽

Aromatase Inhibitor ◽

Cancer Patients ◽

Neuropsychological Functioning ◽

Inhibitor Therapy ◽

Breast Cancer Patients ◽

A prospective pilot study investigating the musculoskeletal pain in postmenopausal breast cancer patients receiving aromatase inhibitor therapy

Current Oncology ◽

10.3747/co.v18i6.909 ◽

2011 ◽

Vol 18 (6) ◽

Cited By ~ 8

Author(s):

A. Robidoux ◽

E. Rich ◽

N.J. Bureau ◽

S. Mader ◽

D. Laperrière ◽

...

Keyword(s):

Breast Cancer ◽

Pilot Study ◽

Aromatase Inhibitor ◽

Cancer Patients ◽

Musculoskeletal Pain ◽

Postmenopausal Breast Cancer ◽

Inhibitor Therapy ◽

Breast Cancer Patients ◽

Prospective Pilot Study

Are Estring® and Vagifem® Equally Effective and Safe for the Treatment of Urogenital Atrophy in Breast Cancer Patients on Aromatase Inhibitor Therapy?

Clinical Oncology ◽

10.1016/j.clon.2012.06.009 ◽

2012 ◽

Vol 24 (8) ◽

pp. e128-e129 ◽

Cited By ~ 6

Author(s):

C.E. Simmons ◽

I. Kuchuk ◽

O.C. Freedman ◽

T. Colgan ◽

A. Dodd ◽

...

Keyword(s):

Breast Cancer ◽

Aromatase Inhibitor ◽

Cancer Patients ◽

Inhibitor Therapy ◽

Breast Cancer Patients ◽

Urogenital Atrophy

Study of Neurobehavioral Symptoms and Impairments in Breast Cancer Patients Receiving Adjuvant Aromatase Inhibitor Therapy.

10.1158/0008-5472.sabcs-09-4084 ◽

2009 ◽

Author(s):

J. Weaver ◽

S. Stark ◽

K. Shahverdi ◽

S. Jeter ◽

...

Keyword(s):

Breast Cancer ◽

Aromatase Inhibitor ◽

Cancer Patients ◽

Inhibitor Therapy ◽

Breast Cancer Patients ◽

Neurobehavioral Symptoms

Modification of Abdominal Fat Distribution After Aromatase Inhibitor Therapy in Breast Cancer Patients Visualized Using 3-D Computed Tomography Volumetry

Clinical Breast Cancer ◽

10.1016/j.clbc.2014.02.003 ◽

2014 ◽

Vol 14 (5) ◽

pp. 365-370 ◽

Cited By ~ 6

Author(s):

Sofia Battisti ◽

Francesco Maria Guida ◽

Federica Coppa ◽

Donata M. Vaccaro ◽

Daniele Santini ◽

...

Keyword(s):

Breast Cancer ◽

Computed Tomography ◽

Aromatase Inhibitor ◽

Cancer Patients ◽

Fat Distribution ◽

Abdominal Fat ◽

Inhibitor Therapy ◽

Breast Cancer Patients ◽

Computed Tomography Volumetry

Fulvestrant with or without selumetinib, a MEK 1/2 inhibitor, in breast cancer progressing after aromatase inhibitor therapy: A multicentre randomised placebo-controlled double-blind phase II trial, SAKK 21/08

European Journal of Cancer ◽

10.1016/j.ejca.2015.03.016 ◽

2015 ◽

Vol 51 (10) ◽

pp. 1212-1220 ◽

Cited By ~ 22

Author(s):

Khalil Zaman ◽

Ralph Winterhalder ◽

Christoph Mamot ◽

Ursula Hasler-Strub ◽

Christoph Rochlitz ◽

...

Keyword(s):

Breast Cancer ◽

Aromatase Inhibitor ◽

Phase Ii ◽

Phase Ii Trial ◽

Inhibitor Therapy ◽

Double Blind ◽

Identifying breast cancer patients most likely to benefit from aromatase inhibitor therapy after adjuvant tamoxifen

Cancer ◽

10.1002/cncr.22613 ◽

2007 ◽

Vol 109 (9) ◽

pp. 1927-1928

Author(s):

Christopher M. Booth ◽

Joseph L. Pater ◽

Paul E. Goss

Keyword(s):

Breast Cancer ◽

Aromatase Inhibitor ◽

Cancer Patients ◽

Inhibitor Therapy ◽

Adjuvant Tamoxifen ◽

Breast Cancer Patients ◽

Bi-weekly docetaxel and gemcitabine regimen in her-2-negative and anthracycline-pretreated metastatic breast cancer patients: a multicenter phase II trial

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-011-1570-7 ◽

2011 ◽

Vol 68 (4) ◽

pp. 1009-1016 ◽

Cited By ~ 2

Author(s):

R. Murialdo ◽

F. Bertolotti ◽

G. Pastorino ◽

M. Mencoboni ◽

M. Bergaglio ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

Weekly Docetaxel ◽

Multicenter Phase ◽

Her 2

FLT-PET (Fluorothymidine) and Ki-67 to measure effects of a short course of aromatase inhibitor therapy in ER+ breast cancer patients.

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.e22161 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. e22161-e22161

Author(s):

Hannah M. Linden ◽

Lanell Peterson ◽

Brenda F. Kurland ◽

Alena Novakova ◽

Andrew Shields ◽

...

Keyword(s):

Breast Cancer ◽

Aromatase Inhibitor ◽

Cancer Patients ◽

Inhibitor Therapy ◽

Breast Cancer Patients ◽

Ki 67 ◽

Flt Pet ◽

Short Course

Androgens and musculoskeletal symptoms among breast cancer patients on aromatase inhibitor therapy

Breast Cancer Research and Treatment ◽

10.1007/s10549-011-1611-2 ◽

2011 ◽

Vol 130 (2) ◽

pp. 569-577 ◽

Cited By ~ 21

Author(s):

Lisa Gallicchio ◽

Ryan MacDonald ◽

Bethany Wood ◽

Errol Rushovich ◽

Kathy J. Helzlsouer

Keyword(s):

Breast Cancer ◽

Aromatase Inhibitor ◽

Cancer Patients ◽

Inhibitor Therapy ◽

Musculoskeletal Symptoms ◽

Breast Cancer Patients ◽